To evaluate changes in the tumor microenvironment induced by RT53 injection that could explain the increased number of T lymphocytes, we used real-time RT-PCR of tumor extracts to analyze the relative expression of the pro-inflammatory chemokine ligands CCL2 and CXCL10. The gene discussed is CXCL10; the disease is neoplasm.